Capricor Therapeutics Inc (CAPR)

[General_Sevier]

Sure it's a large number. Seeking Alpha wrote and article and it was tweeted as one of their high exposure articles. It says the shares O/S are:

"Capricor has about 870, 000 shares outstanding, the market cap is only about $5 million and has a 6 percent institutional ownership. Its share price ranged from $1.40 to $10.00 in the short period it publicly traded. The announcement of the J&J contract boosted the share price."

It's also clear from the last two days that a small cap alert outfit has pushed this stock in an email blast, mainly between late yesterday and pre-market today.

The incorrect claim of low shares used is before the reverse merger last year. CAPR tells you exactly what is O/S from a presentation on their web site and from the January 8-K.

"As previously reported by the Company on its Current Report on Form 8-K filed with the Securities and Exchange Commission on November 26, 2013, and as announced by the Company in the press release previously issued by the Company on December 20, 2013, the Company’s common stock is trading on the OTC Markets under the new ticker symbol “CAPR,” which such symbol is effective as of December 20, 2013. There are approximately 11,687,430 shares of Company common stock issued and outstanding."

From a December presentation:

http://cdn.irdirect.net/PIR/632/466/2013%20Piper%20Jaffray%20Healthcare%20Conference.pdf

Current share price $2.30 (12.3.13)
Current Market Cap = Approx. $27M
Approx. Total Outstanding Shares = 11,687,835
Approx. Fully Diluted Shares = 16,908,660

From the January presention (they show shares O/S but not the options or fully diluted total):

http://cdn.irdirect.net/PIR/632/560/JPM28CapricorTherapeuticsInc.29.pdf

Current Market Cap = ~$91M (stock price (1/10/14) = $7.75)
Approximate Total Outstanding Shares = 11,687,430

Hope that helps.